Home
About
Overview
Sharing Data
ORCID
Help
History (64)
Unfavorable therapeutic index of cisplatin/gemcitabine/vinorelbine in advanced non-small-cell lung cancer.
Developing network adequacy standards for VA Community Care.
Novel candidate genes important for asthma and hypertension comorbidity revealed from associative gene networks.
Tailoring tyrosine kinase inhibitors to fit the lung cancer genome.
Reviewing concomitant medications for participants in oncology clinical trials.
See All 64 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Reviewing concomitant medications for participants in oncology clinical trials.
McGahey KE, Weiss GJ. Reviewing concomitant medications for participants in oncology clinical trials. Am J Health Syst Pharm. 2017 Apr 15; 74(8):580-586.
View in:
PubMed
subject areas
Adult
Antineoplastic Agents
Clinical Trials as Topic
Drug Interactions
Drugs, Investigational
Humans
Neoplasms
Practice Guidelines as Topic
authors with profiles
Glen Weiss MD, MBA